0001179110-14-001313.txt : 20140123 0001179110-14-001313.hdr.sgml : 20140123 20140123170110 ACCESSION NUMBER: 0001179110-14-001313 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20140121 FILED AS OF DATE: 20140123 DATE AS OF CHANGE: 20140123 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: MEDICINES CO /DE CENTRAL INDEX KEY: 0001113481 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 043324394 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 8 SYLVAN WAY CITY: PARSIPPANY STATE: NJ ZIP: 07054 BUSINESS PHONE: 973-290-6000 MAIL ADDRESS: STREET 1: 8 SYLVAN WAY CITY: PARSIPPANY STATE: NJ ZIP: 07054 FORMER COMPANY: FORMER CONFORMED NAME: MEDICINES CO/ MA DATE OF NAME CHANGE: 20000504 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Antinori Paul Michael CENTRAL INDEX KEY: 0001318459 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 000-31191 FILM NUMBER: 14543595 MAIL ADDRESS: STREET 1: THE MEDICINES COMPANY STREET 2: 8 SYLVAN WAY CITY: PARSIPPANY STATE: NJ ZIP: 07054 4 1 edgar.xml FORM 4 - X0306 4 2014-01-21 0 0001113481 MEDICINES CO /DE MDCO 0001318459 Antinori Paul Michael 8 SYLVAN WAY PARSIPPANY NJ 07054 0 1 0 0 Sr. VP & General Counsel Common Stock 2014-01-21 4 M 0 10500 7.31 A 41912 D Common Stock 2014-01-21 4 S 0 10500 38.0024 D 31412 D Common Stock 2014-01-21 4 M 0 20000 14.82 A 51412 D Common Stock 2014-01-21 4 S 0 20000 38.0907 D 31412 D Common Stock 2014-01-21 4 M 0 7000 17.45 A 38412 D Common Stock 2014-01-21 4 S 0 7000 37.8171 D 31412 D Common Stock 2014-01-21 4 S 0 383 38.0526 D 31029 D Stock Option (right-to-buy) 7.31 2014-01-21 4 M 0 10500 D 2020-02-19 Common Stock 10500 2000 D Stock Option (right-to-buy) 14.82 2014-01-21 4 M 0 20000 D 2020-09-17 Common Stock 20000 8330 D Stock Option (right-to-buy) 17.45 2014-01-21 4 M 0 7000 D 2021-02-18 Common Stock 7000 6333 D The common stock sales were effected pursuant to a Rule 10b5-1 program adopted by the reporting person on December 13, 2013. Represents the weighted average sales price of the shares sold ranging from a low of $37.77 to a high of $38.31 per share. The undersigned undertakes, upon request by the Commission staff, the issuer or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price. Represents the weighted average sales price of the shares sold ranging from a low of $37.72 to a high of $38.46 per share. The undersigned undertakes, upon request by the Commission staff, the issuer or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price. Represents the weighted average sales price of the shares sold ranging from a low of $37.70 to a high of $38.06 per share. The undersigned undertakes, upon request by the Commission staff, the issuer or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price. Represents the weighted average sales price of the shares sold ranging from a low of $38.05 to a high of $38.06 per share. The undersigned undertakes, upon request by the Commission staff, the issuer or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price. This option vests in forty-eight equal monthly installments beginning on March 19, 2010. This option vests in forty-eight equal monthly installments beginning October 17, 2010. This option vests in forty-eight equal monthly installments beginning on March 18, 2011. Not applicable. /s/ Paul M. Antinori 2014-01-23